Ganciclovir Medi-Market 500 mg is indicated for the treatment of CMV retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (AIDS). Ganciclovir Medi-Market 500 mg is also indicated for the prevention of CMV disease in transplant recipients at risk for CMV disease.